Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Risk assessments in fungal spore and bacterial spore excursions

SMi Group
Posted on: 26 Sep 16
Risk assessments in fungal spore and bacterial spore excursions

~~SMi Group reports: the 6th annual Pharmaceutical Microbiology conference will be returning to Holiday Inn Kensington Forum, London, UK on 18 – 19 January 2017.
The event will gather leading microbiology experts to discuss hot industry topics such as contamination and endotoxins, quality assurance and control, environmental monitoring, new mechanisms of detection and much more.
SMi group is delighted to have Jim Polarine, Senior Technical Service Manager, STERIS Corporation giving an exclusive presentation on day 1 of the conference: Risk assessments in fungal spore and bacterial spore excursions.
The bacterial culture media segment is likely to continue its increased share until 2023 due to an expected rise in application in food microbiology, pharmaceutical microbiology, and disease research. With the industry updates it is now time to join both regulatory and industry experts to address the complex challenge that the field is facing.
Jim Polarine will discuss risk assessments conducted on fungal spore and bacterial spore contamination in cleanrooms, current examples of excursion investigations, the latest methods in conducting risk based investigations and risk maps and much more.
Furthermore, Alan Baines, Regional Head of Sales, Asia-Pacific from Lonza Bioscience Solutions will be presenting his case study: effective use of data from the bacterial endotoxins test. Alan will focus on topics such as: managing the flow of data, data integrity and how to simplify OOS and OOT investigations using trend analysis.
To see the full event information please visit:

Expert speaker line-up in 2017 include 2 EU regulatory authority speakers:
• Michael Whaley, Senior Pharmacopoeial Scientist, MHRA
• Ingo Spreitzer, Deputy Head Section Microbial Safety, Paul Ehrlich Institut

New for 2017:
• Chris Day, Manager, Microbiology, Bristol-Myers Squibb
• Brandye Michaels, Group Leader/Senior Principal Scientist Analytical R&D, Microbiology, Pfizer
• Pratixa Patel, Microbiology Director, GSK
• Randall Thompson, Principal Scientist, Shire
• Benoit Ramond, Senior Microbiology Expert, Sanofi

Those who are interested in attendance please note: £400 Early bird will be ending on 30th September
2017 Sponsor: Lonza
For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or
For delegate enquiries contact Matthew Apps +44 (0) 20 7827 6093 or email
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email:

---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

For more information:

Editor's Details

Anna Serazetdinova
SMi Group

Last updated on: 26/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.